bpc-157 heart benefits of ProHealth Longevity BPC-157 – TrustScore®
Description
Pathway specificity matters more than amplitude
Diet and Exercise This is more complicated than it sounds, and dismissing it is a mistake
In the NEJM Phase 2 trial, participants assigned to an initial dose of 4 mg experienced significantly more adverse events than those who started at 2 mg, even when both groups ultimately reached the same target dose
The breadth of tissue types it supports, from tendons and ligaments to gut lining and nerve tissue, suggests fundamental mechanisms that enhance the bodys innate healing capacity rather than simply masking symptoms
